Abstract:Background: Sepsis commonly leads to skeletal muscle atrophy, characterized by substantial muscle weakness and degeneration, ultimately contributing to an adverse prognosis. Studies have shown that programmed cell death is an important factor in the progression of muscle loss in sepsis. However, the precise role and mechanism of pyroptosis in skeletal muscle atrophy are not yet fully comprehended. Therefore, we aimed to examine the role and mechanism of action of the pyroptosis effector protein GSDMD in recognized cellular and mouse models of sepsis. Methods: The levels of GSDMD and N-GSDMD in skeletal muscle were evaluated 2, 4, and 8 days after CLP. Sepsis was produced in mice that lacked the Gsdmd gene (Gsdmd knockout) and in mice with the normal Gsdmd gene (wild-type) using a procedure called cecal ligation and puncture (CLP). The degree of muscular atrophy in the gastrocnemius and tibialis anterior muscles was assessed 72 hours after surgery in the septic mouse model. In addition, the architecture of skeletal muscles, protein expression, and markers associated with pathways leading to muscle atrophy were examined in mice from various groups 72 hours after surgery. The in vitro investigations entailed the use of siRNA to suppress Gsdmd expression in C2C12 cells, followed by stimulation of these cells with lipopolysaccharide (LPS) to evaluate the impact of Gsdmd downregulation on muscle atrophy and the related signaling cascades. Results: This study has demonstrated that the GSDMD protein, known as the "executive" protein of pyroptosis, plays a crucial role in the advancement of skeletal muscle atrophy in septic mice. The expression of N-GSDMD in the skeletal muscle of septic mice was markedly higher compared to the control group. The Gsdmd knockout mice exhibited notable enhancements in survival, muscle strength, and body weight compared to the septic mice. Deletion of the Gsdmd gene reduced muscular wasting in the gastrocnemius and tibialis anterior muscles caused by sepsis. Studies conducted in living organisms (in vivo) and in laboratory conditions (in vitro) have shown that the absence of the Gsdmd gene decreases indicators of muscle loss associated with sepsis by blocking the IL18/AMPK signaling pathway. Conclusion: The results of this study demonstrate that the lack of Gsdmd has a beneficial effect on septic skeletal muscle atrophy by reducing the activation of IL18/AMPK and inhibiting the UPS and autophagy pathways. Therefore, our research provides vital insights into the role of pyroptosis in sepsis-related skeletal muscle wasting, which could potentially lead to the development of therapeutic and interventional approaches for preventing septic skeletal muscle atrophy.

Neuregulin-1β Alleviates Sepsis-Induced Skeletal Muscle Atrophy by Inhibiting Autophagy via AKT/mTOR Signaling Pathway in Rats

Deletion of Nlrp3 protects from inflammation-induced skeletal muscle atrophy

N-Acetylcysteine Attenuates Sepsis-Induced Muscle Atrophy by Downregulating Endoplasmic Reticulum Stress

The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy

Deletion of REDD1 Ameliorates Sepsis‐Induced Decrease in Muscle Protein Synthesis but has Divergent Effects on Proteolytic Signaling

Role Of Ampk Alpha In Skeletal Muscle Glycometabolism Regulation And Adaptation In Relation To Sepsis

Endoplasmic reticulum stress promotes sepsis-induced muscle atrophy via activation of STAT3 and Smad3

Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle

GSDMD knockout alleviates sepsis-associated skeletal muscle atrophy by inhibiting IL18/AMPK signaling

Sciatic Denervation-Induced Skeletal Muscle Atrophy Is Associated With Persistent Inflammation And Increased Mortality During Sepsis

Mild Hypothermia Ameliorates Muscle Wasting in Septic Rats Associated with Hypothalamic AMPK-induced Autophagy and Neuropeptides.

[Nuclear Factor Kappa B Impairs Insulin Signaling Pathway in Skeletal Muscle Cells of Rat with Sepsis].

[Effect of Neuregulin-1 on Heart Function and Inflammatory Mediators in Rats with Sepsis].

Estrogen Maintains Skeletal Muscle in Septic Rats Associated with Altering Hypothalamic Inflammation and Neuropeptides

Necroptosis Mediates Muscle Protein Degradation in a Cachexia Model of Weanling Pig with Lipopolysaccharide Challenge

Sepsis causes neutrophil infiltration in muscle leading to muscle atrophy and weakness in mice

Parkin Overexpression Attenuates Sepsis-Induced Muscle Wasting

Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis

Local insulin-like growth factor I prevents sepsis-induced muscle atrophy

Myostatin deficiency not only prevents muscle wasting but also improves survival in septic mice

The AKT/mTOR Pathway Mediates Neuronal Protective Effects of Erythropoietin in Sepsis